A dinucleotide motif in oligonucleotides shows potent immunomodulatory activity and overrides species-specific recognition observed with CpG motif
about
Broad-Spectrum Drugs Against Viral AgentsAn in situ autologous tumor vaccination with combined radiation therapy and TLR9 agonist therapyImmune-Stimulatory Dinucleotide at the 5'-End of Oligodeoxynucleotides Is Critical for TLR9-Mediated Immune Responses.Immunomodulatory oligonucleotides containing a cytosine-phosphate-2'-deoxy-7-deazaguanosine motif as potent toll-like receptor 9 agonistsImmunomodulatory Agents with Antivascular Activity in the Treatment of Non-Small Cell Lung Cancer: Focus on TLR9 Agonists, IMiDs and NGR-TNF.Novel drugs targeting Toll-like receptors for antiviral therapy.Design and Structural Requirements of the Potent and Safe TLR-9 Agonistic Immunomodulator MGN1703.Novel oligodeoxynucleotide agonists of TLR9 containing N3-Me-dC or N1-Me-dG modifications.TLR9 agonist acts by different mechanisms synergizing with bevacizumab in sensitive and cetuximab-resistant colon cancer xenograftsStabilized immune modulatory RNA compounds as agonists of Toll-like receptors 7 and 8.Modulation of gene expression by antisense and antigene oligodeoxynucleotides and small interfering RNA.Immune mechanisms and therapeutic potential of CpG oligodeoxynucleotides.Impact of secondary structure of toll-like receptor 9 agonists on interferon alpha induction.Immunological and hematological toxicities challenging clinical translation of nucleic acid-based therapeutics.Advances in Antiviral Therapies Targeting Toll-like Receptors.Coadministration of telomerase genetic vaccine and a novel TLR9 agonist in nonhuman primates.CpG and Non-CpG oligodeoxynucleotides induce differential proinflammatory gene expression profiles in liver and peripheral blood leukocytes in mice.
P2860
Q27487859-A7EE4244-0BE4-490E-B5E3-E948130CFCD8Q28729093-8410C1CA-973F-4F51-827B-A60CCEE1760CQ33635971-E98004CC-87FA-4C7A-8F57-D48925615DE1Q33784491-49208CAD-7A88-49A7-9C18-9361C8205148Q33960866-41780A9D-5E2F-4136-B970-6657A8F250D4Q34999938-17739B70-BA62-4BB4-9653-BFD6F5EB5E3EQ35635250-1C46E9F3-ACDE-466B-A48E-8E85F218BB64Q35864900-F98175BD-0E86-4B57-A60D-06E266D49D54Q35894601-94529C60-5C4C-4620-A106-C5E37971B60BQ35963017-099D0B75-0EB4-44FE-9AA9-EA44F2BE9BA8Q36316652-9A03E2AE-81D0-4C57-9211-FA5E61D36C3FQ36526351-9361F108-F817-4E71-BC23-24499139B119Q36993487-6F01D169-477E-4081-8E8D-9C67CFC5E849Q38504825-6EF35778-537F-4943-A54B-B660ADD3058DQ38733975-5F859505-33A0-45E8-9678-9B444C057F30Q39502335-4E0DB5EC-9826-47C3-A5CB-E88EE6C13A02Q46796731-C3D953C3-595C-42EA-882B-A3708F2518BF
P2860
A dinucleotide motif in oligonucleotides shows potent immunomodulatory activity and overrides species-specific recognition observed with CpG motif
description
2003 nî lūn-bûn
@nan
2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
A dinucleotide motif in oligon ...... nition observed with CpG motif
@ast
A dinucleotide motif in oligon ...... nition observed with CpG motif
@en
type
label
A dinucleotide motif in oligon ...... nition observed with CpG motif
@ast
A dinucleotide motif in oligon ...... nition observed with CpG motif
@en
prefLabel
A dinucleotide motif in oligon ...... nition observed with CpG motif
@ast
A dinucleotide motif in oligon ...... nition observed with CpG motif
@en
P2093
P2860
P356
P1476
A dinucleotide motif in oligon ...... nition observed with CpG motif
@en
P2093
Cathrine F Knetter
Daqing Wang
Ekambar R Kandimalla
Fu-Gang Zhu
Jimmy X Tang
Jin-Yan Tang
Lakshmi Bhagat
Sudhir Agrawal
Yan-Ping Cong
P2860
P304
14303-14308
P356
10.1073/PNAS.2335947100
P407
P50
P577
2003-11-10T00:00:00Z